Treatment of Acute Anxiety

The Preferred treatment for acute anxiety is psychological intervention. See Psychological Interventions for Anxiety and Depression section for further information

Benzodiazepines

The use of benzodiazepines for acute anxiety symptoms is generally not recommended because of their potential to cause physical dependence and withdrawal symptoms. They should only be considered as a short-term treatment option during crises or where anxiety is severe or disabling. The lowest possible dose should be prescribed for the shortest period of time, while longer-term treatment strategies are put in place, with the patient reviewed regularly. Treatment should not exceed 2–4 weeks. The use of benzodiazepines in an acute presentation of panic disorder is not recommended.
In line with local established practice, any supplies of diazepam should be made as 2mg tablets in order to minimise the risk of diversion.

Buspirone

The use of buspirone is not included in the NHS Lanarkshire Joint Adult Formulary and is not endorsed by NICE. Buspirone is licensed for the treatment of short-term management of anxiety disorders and to relieve the symptoms of anxiety with or without accompanying symptoms of depression. 

 

 

Editorial Information

Last reviewed: 04/01/2024

Author(s): NHSL.

Version: Please refer to the introduction section for an explanation of the review dates above.

Approved By: ADTC

Reviewer name(s): ADTC.